These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR. Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875 [Abstract] [Full Text] [Related]
5. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ravandi F, O'Brien SM, Cortes JE, Thomas DM, Garris R, Faderl S, Burger JA, Rytting ME, Ferrajoli A, Wierda WG, Verstovsek S, Champlin R, Kebriaei P, McCue DA, Huang X, Jabbour E, Garcia-Manero G, Estrov Z, Kantarjian HM. Cancer; 2015 Dec 01; 121(23):4158-64. PubMed ID: 26308885 [Abstract] [Full Text] [Related]
6. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055 [Abstract] [Full Text] [Related]
7. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486). Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM, Eastern Cooperative Oncology Group Study. Leuk Lymphoma; 2003 Sep 15; 44(9):1515-21. PubMed ID: 14565653 [Abstract] [Full Text] [Related]
8. Treatment of acute lymphoblastic leukaemia (ALL). Jacobs P, Wood L. Eur J Haematol; 1992 Aug 15; 49(2):53-8. PubMed ID: 1397240 [Abstract] [Full Text] [Related]
9. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L. Leukemia; 1993 Aug 15; 7(8):1236-41. PubMed ID: 8350624 [Abstract] [Full Text] [Related]
10. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group. Eur J Haematol; 2007 Feb 15; 78(2):102-10. PubMed ID: 17087744 [Abstract] [Full Text] [Related]
11. Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Colgan JP, Andersen J, Habermann TM, Earle JD, O'Connell MJ, Neiman RS, Mann RB, Glick JH. Leuk Lymphoma; 1994 Oct 15; 15(3-4):291-6. PubMed ID: 7866277 [Abstract] [Full Text] [Related]
20. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S. J Clin Oncol; 1996 Apr 15; 14(4):1252-61. PubMed ID: 8648381 [Abstract] [Full Text] [Related] Page: [Next] [New Search]